Welcome to LookChem.com Sign In|Join Free
  • or
dimethyl p-chlorophenoxyisobutyrylphosphonate is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

81928-53-2

Post Buying Request

81928-53-2 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

81928-53-2 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 81928-53-2 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 8,1,9,2 and 8 respectively; the second part has 2 digits, 5 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 81928-53:
(7*8)+(6*1)+(5*9)+(4*2)+(3*8)+(2*5)+(1*3)=152
152 % 10 = 2
So 81928-53-2 is a valid CAS Registry Number.

81928-53-2SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 20, 2017

Revision Date: Aug 20, 2017

1.Identification

1.1 GHS Product identifier

Product name dimethyl p-chlorophenoxyisobutyrylphosphonate

1.2 Other means of identification

Product number -
Other names -

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:81928-53-2 SDS

81928-53-2Downstream Products

81928-53-2Relevant academic research and scientific papers

gem-Diphosphonate and gem-phosphonate-phosphate compounds with specific high density lipoprotein inducing activity

Nguyen,Niesor,Bentzen

, p. 1426 - 1433 (2007/10/02)

New diphosphonate compounds and related derivatives were synthesized and investigated for their activity in specifically inducing plasma high density lipoproteins (HDL) and high density lipoprotein cholesterol (HDL-C) in normal rats. The screening of nume

Anti-atherosclerotic pharmaceutical compositions containing diphosphonate compounds

-

, (2008/06/13)

The present invention relates to a pharmaceutical composition for increasing the relative quantity of circulating high density lipoproteins favorable augmentating the alpha/beta lipoprotein cholesterol ratios and clearing cholesterol and lipids from certain tissues and inducing hypotensive activity comprising administering to a human an effective amount of a compound of the formula: STR1 where X is H, OH, or STR2 R and R' identical or different are H, CH3 or C2 H5 ; m is zero or 1; and A is selected from the group comprising (CH3)3 C--, Y--C6 H4 --, Y--C6 H4 --O--C(CH3)2 --, Y--C6 H4 --C(CH3)2 --, Y--C6 H4 --C(O)--C6 H4 --, Y--C6 H4 --(CH2)n -- and Y--C6 H4 --O--(CH2)n --, where n is an integer from 1 to 6 and Y is H, CH3, OCH3, a halogen, and a pharmaceutically acceptable excipient.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 81928-53-2